Qube Research & Technologies (QRT)
KYNB

Qube Research & Technologies (QRT)’s Kyntra Bio KYNB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,399
Closed -$18.5K – 3605
2024
Q4 		$18.5K Sell
1,399
-1,183
-46% -$11K ﹤0.01% 3187
2024
Q3 		$25.8K Buy
+2,582
New +$39K ﹤0.01% 2948
2024
Q1 		– Sell
-15
Closed -$336 – 4592
2023
Q4 		$336 Buy
+15
New +$226 ﹤0.01% 3948
2023
Q3 		– Sell
-18,141
Closed -$1.22M – 4150
2023
Q2 		$1.22M Buy
18,141
+7,363
+68% +$3.05M ﹤0.01% 1228
2023
Q1 		$5.03M Buy
10,778
+9,758
+957% +$5.16M 0.02% 668
2022
Q4 		$408K Buy
+1,020
New +$391K ﹤0.01% 1548
2022
Q2 		– Sell
-906
Closed -$272K – 2686
2022
Q1 		$272K Buy
+906
New +$316K ﹤0.01% 1837
2020
Q1 		– Sell
-201
Closed -$215K – 1298
2019
Q4 		$215K Buy
+201
New +$205K 0.01% 1360

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KYNB Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 1,399 shares — an estimated $18.5K sold.

Qube Research & Technologies (QRT) first reported a position in KYNB in Q4 2019 and held it in 8 quarters. The position peaked at $5.03M in Q1 2023. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,399 Kyntra Bio shares in Q1 2025, an estimated $18.5K.
  • Qube Research & Technologies (QRT) first reported a position in Kyntra Bio in Q4 2019 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Kyntra Bio position peaked at $5.03M in Q1 2023.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.